LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the March 5, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Acuity Brands, Inc. (“Acuity” or the “Company”) (NYSE: AYI) securities between June 29, 2016 and April 3, 2017, inclusive (the “Class Period”). Acuity investors have until March 5, 2018 to file a lead plaintiff motion. To obtain information or actively participate in the class action, please visit the Acuity page on our website at www.glancylaw.com/case/acuity-brands-inc.
Investors suffering losses on their Acuity investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to email@example.com.
The complaint filed in this class action alleges that Defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) known trends were negatively impacting sales of Acuity's products; (2) Acuity's ability to achieve profitable sales growth was overstated; and (3) as a result, defendants' positive statements about Acuity's current and future business and financial prospects lacked a reasonable basis.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of Acuity, you may move the Court no later than March 5, 2018 to ask the Court to appoint you as lead. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.